                         SEQUENCE LISTING

<110>  ITH Immune Therapy Holdings AB
 
<120>  TREATING CANCER

<130>  P117755WO00

<160>  34    

<170>  PatentIn version 3.5

<210>  1
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X is pyroglutamine or Gln

<220>
<221>  X
<222>  (75)..(75)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, in 
       particular K(PEG-Biotin)

<400>  1

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Xaa Pro 
65                  70                  75      


<210>  2
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X is pyroglutamine or Gln

<220>
<221>  X
<222>  (75)..(75)
<223>  X is FmocLys(ivDde)

<400>  2

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Xaa Pro 
65                  70                  75      


<210>  3
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X is pyroglutamine

<220>
<221>  X
<222>  (1)..(1)
<223>  X is pyroglutamine or Gln

<220>
<221>  X
<222>  (75)..(75)
<223>  X is K(PEG-Biotin)

<400>  3

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Xaa Pro 
65                  70                  75      


<210>  4
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  4

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Lys Ser 
65              


<210>  5
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (67)..(67)
<223>  X is FmocLys(ivDde)

<400>  5

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Xaa Ser 
65              


<210>  6
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (67)..(67)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated (e.g. K-biotin), optionally via a spacer molecule 
       such as PEG, in particular K(PEG-Biotin)

<400>  6

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Xaa Ser 
65              


<210>  7
<211>  70
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  7

Ala Ser Asn Phe Asp Cys Cys Leu Gly Tyr Thr Asp Arg Ile Leu His 
1               5                   10                  15      


Pro Lys Phe Ile Val Gly Phe Thr Arg Gln Leu Ala Asn Glu Gly Cys 
            20                  25                  30          


Asp Ile Asn Ala Ile Ile Phe His Thr Lys Lys Lys Leu Ser Val Cys 
        35                  40                  45              


Ala Asn Pro Lys Gln Thr Trp Val Lys Tyr Ile Val Arg Leu Leu Ser 
    50                  55                  60                  


Lys Lys Val Lys Asn Met 
65                  70  


<210>  8
<211>  70
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (68)..(68)
<223>  X is FmocLys(ivDde)

<400>  8

Ala Ser Asn Phe Asp Cys Cys Leu Gly Tyr Thr Asp Arg Ile Leu His 
1               5                   10                  15      


Pro Lys Phe Ile Val Gly Phe Thr Arg Gln Leu Ala Asn Glu Gly Cys 
            20                  25                  30          


Asp Ile Asn Ala Ile Ile Phe His Thr Lys Lys Lys Leu Ser Val Cys 
        35                  40                  45              


Ala Asn Pro Lys Gln Thr Trp Val Lys Tyr Ile Val Arg Leu Leu Ser 
    50                  55                  60                  


Lys Lys Val Xaa Asn Met 
65                  70  


<210>  9
<211>  70
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (68)..(68)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  9

Ala Ser Asn Phe Asp Cys Cys Leu Gly Tyr Thr Asp Arg Ile Leu His 
1               5                   10                  15      


Pro Lys Phe Ile Val Gly Phe Thr Arg Gln Leu Ala Asn Glu Gly Cys 
            20                  25                  30          


Asp Ile Asn Ala Ile Ile Phe His Thr Lys Lys Lys Leu Ser Val Cys 
        35                  40                  45              


Ala Asn Pro Lys Gln Thr Trp Val Lys Tyr Ile Val Arg Leu Leu Ser 
    50                  55                  60                  


Lys Lys Val Xaa Asn Met 
65                  70  


<210>  10
<211>  67
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  10

Lys Pro Val Ser Leu Ser Tyr Arg Cys Pro Cys Arg Phe Phe Glu Ser 
1               5                   10                  15      


His Val Ala Arg Ala Asn Val Lys His Leu Lys Ile Leu Asn Thr Pro 
            20                  25                  30          


Asn Cys Ala Leu Gln Ile Val Ala Arg Leu Lys Asn Asn Asn Arg Gln 
        35                  40                  45              


Val Cys Ile Asp Pro Lys Leu Lys Trp Ile Gln Glu Tyr Leu Glu Lys 
    50                  55                  60                  


Ala Leu Asn 
65          


<210>  11
<211>  66
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (64)..(64)
<223>  X is FmocLys(ivDde)

<400>  11

Lys Pro Val Ser Leu Ser Tyr Arg Cys Pro Cys Arg Phe Phe Glu Ser 
1               5                   10                  15      


His Val Ala Arg Ala Asn Val Lys His Leu Lys Ile Leu Asn Thr Pro 
            20                  25                  30          


Asn Cys Ala Leu Gln Ile Val Ala Arg Leu Lys Asn Asn Asn Arg Gln 
        35                  40                  45              


Val Cys Ile Asp Pro Lys Leu Lys Trp Ile Gln Glu Tyr Leu Glu Ala 
    50                  55                  60                  


Leu Asn 
65      


<210>  12
<211>  67
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (64)..(64)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  12

Lys Pro Val Ser Leu Ser Tyr Arg Cys Pro Cys Arg Phe Phe Glu Ser 
1               5                   10                  15      


His Val Ala Arg Ala Asn Val Lys His Leu Lys Ile Leu Asn Thr Pro 
            20                  25                  30          


Asn Cys Ala Leu Gln Ile Val Ala Arg Leu Lys Asn Asn Asn Arg Gln 
        35                  40                  45              


Val Cys Ile Asp Pro Lys Leu Lys Trp Ile Gln Glu Tyr Leu Glu Xaa 
    50                  55                  60                  


Ala Leu Asn 
65          


<210>  13
<211>  69
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  13

Gly Pro Tyr Gly Ala Asn Met Glu Asp Ser Val Cys Cys Arg Asp Tyr 
1               5                   10                  15      


Val Arg Tyr Arg Leu Pro Leu Arg Val Val Lys His Phe Tyr Trp Thr 
            20                  25                  30          


Ser Asp Ser Cys Pro Arg Pro Gly Val Val Leu Leu Thr Phe Arg Asp 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Arg Val Pro Trp Val Lys Met Ile Leu 
    50                  55                  60                  


Asn Lys Leu Ser Gln 
65                  


<210>  14
<211>  69
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (66)..(66)
<223>  X is FmocLys(ivDde)

<400>  14

Gly Pro Tyr Gly Ala Asn Met Glu Asp Ser Val Cys Cys Arg Asp Tyr 
1               5                   10                  15      


Val Arg Tyr Arg Leu Pro Leu Arg Val Val Lys His Phe Tyr Trp Thr 
            20                  25                  30          


Ser Asp Ser Cys Pro Arg Pro Gly Val Val Leu Leu Thr Phe Arg Asp 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Arg Val Pro Trp Val Lys Met Ile Leu 
    50                  55                  60                  


Asn Xaa Leu Ser Gln 
65                  


<210>  15
<211>  69
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (66)..(66)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, 
       especially K(PEG-Biotin)

<400>  15

Gly Pro Tyr Gly Ala Asn Met Glu Asp Ser Val Cys Cys Arg Asp Tyr 
1               5                   10                  15      


Val Arg Tyr Arg Leu Pro Leu Arg Val Val Lys His Phe Tyr Trp Thr 
            20                  25                  30          


Ser Asp Ser Cys Pro Arg Pro Gly Val Val Leu Leu Thr Phe Arg Asp 
        35                  40                  45              


Lys Glu Ile Cys Ala Asp Pro Arg Val Pro Trp Val Lys Met Ile Leu 
    50                  55                  60                  


Asn Xaa Leu Ser Gln 
65                  


<210>  16
<211>  72
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (72)..(72)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated (e.g. K-biotin), optionally via a spacer molecule 
       such as PEG, in particular K(PEG-Biotin)

<400>  16

Ala Arg Gly Thr Asn Val Gly Arg Glu Cys Cys Leu Glu Tyr Phe Lys 
1               5                   10                  15      


Gly Ala Ile Pro Leu Arg Lys Leu Lys Thr Trp Tyr Gln Thr Ser Glu 
            20                  25                  30          


Asp Cys Ser Arg Asp Ala Ile Val Phe Val Thr Val Gln Gly Arg Ala 
        35                  40                  45              


Ile Cys Ser Asp Pro Asn Asn Lys Arg Val Lys Asn Ala Val Lys Tyr 
    50                  55                  60                  


Leu Gln Ser Leu Glu Arg Ser Xaa 
65                  70          


<210>  17
<211>  72
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (72)..(72)
<223>  X is FmocLys(ivDde)

<400>  17

Ala Arg Gly Thr Asn Val Gly Arg Glu Cys Cys Leu Glu Tyr Phe Lys 
1               5                   10                  15      


Gly Ala Ile Pro Leu Arg Lys Leu Lys Thr Trp Tyr Gln Thr Ser Glu 
            20                  25                  30          


Asp Cys Ser Arg Asp Ala Ile Val Phe Val Thr Val Gln Gly Arg Ala 
        35                  40                  45              


Ile Cys Ser Asp Pro Asn Asn Lys Arg Val Lys Asn Ala Val Lys Tyr 
    50                  55                  60                  


Leu Gln Ser Leu Glu Arg Ser Xaa 
65                  70          


<210>  18
<211>  72
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (72)..(72)
<223>  X is K(PEG-Biotin)

<400>  18

Ala Arg Gly Thr Asn Val Gly Arg Glu Cys Cys Leu Glu Tyr Phe Lys 
1               5                   10                  15      


Gly Ala Ile Pro Leu Arg Lys Leu Lys Thr Trp Tyr Gln Thr Ser Glu 
            20                  25                  30          


Asp Cys Ser Arg Asp Ala Ile Val Phe Val Thr Val Gln Gly Arg Ala 
        35                  40                  45              


Ile Cys Ser Asp Pro Asn Asn Lys Arg Val Lys Asn Ala Val Lys Tyr 
    50                  55                  60                  


Leu Gln Ser Leu Glu Arg Ser Xaa 
65                  70          


<210>  19
<211>  78
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (78)..(78)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated (e.g. K-biotin), optionally via a spacer molecule 
       such as PEG, in particular K(PEG-Biotin)

<400>  19

Gly Thr Asn Asp Ala Glu Asp Cys Cys Leu Ser Val Thr Gln Lys Pro 
1               5                   10                  15      


Ile Pro Gly Tyr Ile Val Arg Asn Phe His Tyr Leu Leu Ile Lys Asp 
            20                  25                  30          


Gly Cys Arg Val Pro Ala Val Val Phe Thr Thr Leu Arg Gly Arg Gln 
        35                  40                  45              


Leu Cys Ala Pro Pro Asp Gln Pro Trp Val Glu Arg Ile Ile Gln Arg 
    50                  55                  60                  


Leu Gln Arg Thr Ser Ala Lys Met Lys Arg Arg Ser Ser Xaa 
65                  70                  75              


<210>  20
<211>  78
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (78)..(78)
<223>  X is FmocLys(ivDde)

<400>  20

Gly Thr Asn Asp Ala Glu Asp Cys Cys Leu Ser Val Thr Gln Lys Pro 
1               5                   10                  15      


Ile Pro Gly Tyr Ile Val Arg Asn Phe His Tyr Leu Leu Ile Lys Asp 
            20                  25                  30          


Gly Cys Arg Val Pro Ala Val Val Phe Thr Thr Leu Arg Gly Arg Gln 
        35                  40                  45              


Leu Cys Ala Pro Pro Asp Gln Pro Trp Val Glu Arg Ile Ile Gln Arg 
    50                  55                  60                  


Leu Gln Arg Thr Ser Ala Lys Met Lys Arg Arg Ser Ser Xaa 
65                  70                  75              


<210>  21
<211>  78
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (78)..(78)
<223>  X is biotinylated lysine

<400>  21

Gly Thr Asn Asp Ala Glu Asp Cys Cys Leu Ser Val Thr Gln Lys Pro 
1               5                   10                  15      


Ile Pro Gly Tyr Ile Val Arg Asn Phe His Tyr Leu Leu Ile Lys Asp 
            20                  25                  30          


Gly Cys Arg Val Pro Ala Val Val Phe Thr Thr Leu Arg Gly Arg Gln 
        35                  40                  45              


Leu Cys Ala Pro Pro Asp Gln Pro Trp Val Glu Arg Ile Ile Gln Arg 
    50                  55                  60                  


Leu Gln Arg Thr Ser Ala Lys Met Lys Arg Arg Ser Ser Xaa 
65                  70                  75              


<210>  22
<211>  73
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  22

Phe Pro Met Phe Lys Arg Gly Arg Cys Leu Cys Ile Gly Pro Gly Val 
1               5                   10                  15      


Lys Ala Val Lys Val Ala Asp Ile Glu Lys Ala Ser Ile Met Tyr Pro 
            20                  25                  30          


Ser Asn Asn Cys Asp Lys Ile Glu Val Ile Ile Thr Leu Lys Glu Asn 
        35                  40                  45              


Lys Gly Gln Arg Cys Leu Asn Pro Lys Ser Lys Gln Ala Arg Leu Ile 
    50                  55                  60                  


Ile Lys Lys Val Glu Arg Lys Asn Phe 
65                  70              


<210>  23
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (74)..(74)
<223>  X =a residue that can be biotinylated, such as lysine, ornithine 
       or diaminopropionic acid and optionally is biotinylated, 
       optionally via a spacer molecule such as PEG.  The amino acid 
       residue may be added via a spacer molecule such as PEG.

<400>  23

Phe Pro Met Phe Lys Arg Gly Arg Cys Leu Cys Ile Gly Pro Gly Val 
1               5                   10                  15      


Lys Ala Val Lys Val Ala Asp Ile Glu Lys Ala Ser Ile Met Tyr Pro 
            20                  25                  30          


Ser Asn Asn Cys Asp Lys Ile Glu Val Ile Ile Thr Leu Lys Glu Asn 
        35                  40                  45              


Lys Gly Gln Arg Cys Leu Asn Pro Lys Ser Lys Gln Ala Arg Leu Ile 
    50                  55                  60                  


Ile Lys Lys Val Glu Arg Lys Asn Phe Xaa 
65                  70                  


<210>  24
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (74)..(74)
<223>  X is PEG-K(ivDde)

<400>  24

Phe Pro Met Phe Lys Arg Gly Arg Cys Leu Cys Ile Gly Pro Gly Val 
1               5                   10                  15      


Lys Ala Val Lys Val Ala Asp Ile Glu Lys Ala Ser Ile Met Tyr Pro 
            20                  25                  30          


Ser Asn Asn Cys Asp Lys Ile Glu Val Ile Ile Thr Leu Lys Glu Asn 
        35                  40                  45              


Lys Gly Gln Arg Cys Leu Asn Pro Lys Ser Lys Gln Ala Arg Leu Ile 
    50                  55                  60                  


Ile Lys Lys Val Glu Arg Lys Asn Phe Xaa 
65                  70                  


<210>  25
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (74)..(74)
<223>  X is PEG-K(Biotin)

<400>  25

Phe Pro Met Phe Lys Arg Gly Arg Cys Leu Cys Ile Gly Pro Gly Val 
1               5                   10                  15      


Lys Ala Val Lys Val Ala Asp Ile Glu Lys Ala Ser Ile Met Tyr Pro 
            20                  25                  30          


Ser Asn Asn Cys Asp Lys Ile Glu Val Ile Ile Thr Leu Lys Glu Asn 
        35                  40                  45              


Lys Gly Gln Arg Cys Leu Asn Pro Lys Ser Lys Gln Ala Arg Leu Ile 
    50                  55                  60                  


Ile Lys Lys Val Glu Arg Lys Asn Phe Xaa 
65                  70                  


<210>  26
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (64)..(64)
<223>  X = Norleucine

<220>
<221>  X
<222>  (72)..(72)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  26

Xaa Gly Val Phe Glu Asp Cys Cys Leu Ala Tyr His Tyr Pro Ile Gly 
1               5                   10                  15      


Trp Ala Val Leu Arg Arg Ala Trp Thr Tyr Arg Ile Gln Glu Val Ser 
            20                  25                  30          


Gly Ser Cys Asn Leu Pro Ala Ala Ile Phe Tyr Leu Pro Lys Arg His 
        35                  40                  45              


Arg Lys Val Cys Gly Asn Pro Lys Ser Arg Glu Val Gln Arg Ala Xaa 
    50                  55                  60                  


Lys Leu Leu Asp Ala Arg Asn Xaa Val Phe 
65                  70                  


<210>  27
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (64)..(64)
<223>  X = Norleucine

<220>
<221>  X
<222>  (72)..(72)
<223>  X is K(ivDde)

<400>  27

Xaa Gly Val Phe Glu Asp Cys Cys Leu Ala Tyr His Tyr Pro Ile Gly 
1               5                   10                  15      


Trp Ala Val Leu Arg Arg Ala Trp Thr Tyr Arg Ile Gln Glu Val Ser 
            20                  25                  30          


Gly Ser Cys Asn Leu Pro Ala Ala Ile Phe Tyr Leu Pro Lys Arg His 
        35                  40                  45              


Arg Lys Val Cys Gly Asn Pro Lys Ser Arg Glu Val Gln Arg Ala Xaa 
    50                  55                  60                  


Lys Leu Leu Asp Ala Arg Asn Xaa Val Phe 
65                  70                  


<210>  28
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (64)..(64)
<223>  X = Norleucine

<220>
<221>  X
<222>  (72)..(72)
<223>  X is K(PEG-Biotin)

<400>  28

Xaa Gly Val Phe Glu Asp Cys Cys Leu Ala Tyr His Tyr Pro Ile Gly 
1               5                   10                  15      


Trp Ala Val Leu Arg Arg Ala Trp Thr Tyr Arg Ile Gln Glu Val Ser 
            20                  25                  30          


Gly Ser Cys Asn Leu Pro Ala Ala Ile Phe Tyr Leu Pro Lys Arg His 
        35                  40                  45              


Arg Lys Val Cys Gly Asn Pro Lys Ser Arg Glu Val Gln Arg Ala Xaa 
    50                  55                  60                  


Lys Leu Leu Asp Ala Arg Asn Xaa Val Phe 
65                  70                  


<210>  29
<211>  88
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (87)..(87)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  29

Phe Leu Leu Pro Pro Ser Thr Ala Cys Cys Thr Gln Leu Tyr Arg Lys 
1               5                   10                  15      


Pro Leu Ser Asp Lys Leu Leu Arg Lys Val Ile Gln Val Glu Leu Gln 
            20                  25                  30          


Glu Ala Asp Gly Asp Cys His Leu Gln Ala Phe Val Leu His Leu Ala 
        35                  40                  45              


Gln Arg Ser Ile Cys Ile His Pro Gln Asn Pro Ser Leu Ser Gln Trp 
    50                  55                  60                  


Phe Glu His Gln Glu Arg Lys Leu His Gly Thr Leu Pro Lys Leu Asn 
65                  70                  75                  80  


Phe Gly Met Leu Arg Lys Xaa Gly 
                85              


<210>  30
<211>  88
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (87)..(87)
<223>  X is K(ivDde)

<400>  30

Phe Leu Leu Pro Pro Ser Thr Ala Cys Cys Thr Gln Leu Tyr Arg Lys 
1               5                   10                  15      


Pro Leu Ser Asp Lys Leu Leu Arg Lys Val Ile Gln Val Glu Leu Gln 
            20                  25                  30          


Glu Ala Asp Gly Asp Cys His Leu Gln Ala Phe Val Leu His Leu Ala 
        35                  40                  45              


Gln Arg Ser Ile Cys Ile His Pro Gln Asn Pro Ser Leu Ser Gln Trp 
    50                  55                  60                  


Phe Glu His Gln Glu Arg Lys Leu His Gly Thr Leu Pro Lys Leu Asn 
65                  70                  75                  80  


Phe Gly Met Leu Arg Lys Xaa Gly 
                85              


<210>  31
<211>  88
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (87)..(87)
<223>  X is K(PEG-Biotin)

<400>  31

Phe Leu Leu Pro Pro Ser Thr Ala Cys Cys Thr Gln Leu Tyr Arg Lys 
1               5                   10                  15      


Pro Leu Ser Asp Lys Leu Leu Arg Lys Val Ile Gln Val Glu Leu Gln 
            20                  25                  30          


Glu Ala Asp Gly Asp Cys His Leu Gln Ala Phe Val Leu His Leu Ala 
        35                  40                  45              


Gln Arg Ser Ile Cys Ile His Pro Gln Asn Pro Ser Leu Ser Gln Trp 
    50                  55                  60                  


Phe Glu His Gln Glu Arg Lys Leu His Gly Thr Leu Pro Lys Leu Asn 
65                  70                  75                  80  


Phe Gly Met Leu Arg Lys Xaa Gly 
                85              


<210>  32
<211>  77
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  32

Val Pro Leu Ser Arg Thr Val Arg Cys Thr Cys Ile Ser Ile Ser Asn 
1               5                   10                  15      


Gln Pro Val Asn Pro Arg Ser Leu Glu Lys Leu Glu Ile Ile Pro Ala 
            20                  25                  30          


Ser Gln Phe Cys Pro Arg Val Glu Ile Ile Ala Thr Met Lys Lys Lys 
        35                  40                  45              


Gly Glu Lys Arg Cys Leu Asn Pro Glu Ser Lys Ala Ile Lys Asn Leu 
    50                  55                  60                  


Leu Lys Ala Val Ser Lys Glu Arg Ser Lys Arg Ser Pro 
65                  70                  75          


<210>  33
<211>  78
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (78)..(78)
<223>  X is K(ivDde), optionally attached via a spacer such as PEG, e.g.
       -PEG-K(ivDde)

<400>  33

Val Pro Leu Ser Arg Thr Val Arg Cys Thr Cys Ile Ser Ile Ser Asn 
1               5                   10                  15      


Gln Pro Val Asn Pro Arg Ser Leu Glu Lys Leu Glu Ile Ile Pro Ala 
            20                  25                  30          


Ser Gln Phe Cys Pro Arg Val Glu Ile Ile Ala Thr Met Lys Lys Lys 
        35                  40                  45              


Gly Glu Lys Arg Cys Leu Asn Pro Glu Ser Lys Ala Ile Lys Asn Leu 
    50                  55                  60                  


Leu Lys Ala Val Ser Lys Glu Arg Ser Lys Arg Ser Pro Xaa 
65                  70                  75              


<210>  34
<211>  78
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (78)..(78)
<223>  X =a residue that can be biotinylated, such as lysine, ornithine 
       or diaminopropionic acid and optionally is biotinylated, 
       optionally via a spacer molecule such as PEG.  The amino acid 
       residue may be added via a spacer molecule such as PEG.

<400>  34

Val Pro Leu Ser Arg Thr Val Arg Cys Thr Cys Ile Ser Ile Ser Asn 
1               5                   10                  15      


Gln Pro Val Asn Pro Arg Ser Leu Glu Lys Leu Glu Ile Ile Pro Ala 
            20                  25                  30          


Ser Gln Phe Cys Pro Arg Val Glu Ile Ile Ala Thr Met Lys Lys Lys 
        35                  40                  45              


Gly Glu Lys Arg Cys Leu Asn Pro Glu Ser Lys Ala Ile Lys Asn Leu 
    50                  55                  60                  


Leu Lys Ala Val Ser Lys Glu Arg Ser Lys Arg Ser Pro Xaa 
65                  70                  75              


